Pioneering Innovative Anti-Cancer Therapies through Natural Killer Cell Derived Extracellular Vesicle Technology (EV)
Defeating Difficult Cancers
Malignant, distal, refractory, relapsed, chemotherapy-resistant types of cancer that pose significant challenges in treatment and require innovative therapeutic approaches.
.png)
future of cancer treatment
We are shaping the future of oncology with therapies that are effective and accessible against difficult tumors.
Natural Killer Extracellular Vesicles target and eliminate cancer cells, They are potent cytotoxic molecules, based on perforin and granzyme technology, causing apoptosis in tumor cells.
NKEVs enhance stability, prevent immune evasion, and penetrate solid tumors efficiently. They are naturally biocompatible, reducing the risk of immune rejection.
NKEVs are a safe and scalable immunotherapy option due to their cell-free nature, eliminating the risk of graft-versus-host disease (GVHD) and immune overactivation. They can be stored at standard temperature with long shelf-life, stable formulation, maintaining potency over extended periods without the need for cryopreservation. They are biocompatible, able to cross blood brain barrier.
We are researching new AI-powered imaging to combine with NKEV treatment for early detection of difficult pancreatic cancers. Once detected, AI guides the targeted delivery of NKEV treatment directly to tumors, maximizing therapeutic effects while sparing healthy tissue. The AI integration enables a personalized, minimally invasive, and effective cancer treatment approach.
.png)
Accelerating Natural Killer Derived Treatments
Natural Killer (NK) cells are at the forefront of innovative therapies, offering promising advancements in the treatment of various diseases. These cells, a crucial component of the immune system, have the unique ability to target.